Literature DB >> 8223633

Expression of human cytochrome c oxidase subunits during fetal development.

G Bonne1, P Seibel, S Possekel, C Marsac, B Kadenbach.   

Abstract

Expression of human cytochrome c oxidase (COX) subunits was examined at fetal (20-28 weeks) and adult state by Northern blot hybridization with mRNA from liver, heart, skeletal muscle, and intestine. The data were related to COX and citrate synthase activities and to immunodetected COX subunits (II/III, IV, VIIaH). In liver little changes of COX transcripts are observed from fetal to adult state. In contrast, in heart and skeletal muscle all transcripts of COX subunits increase between 2-20-fold, when related to the amount of 28S rRNA. In fetal heart and skeletal muscle the relative amounts of the liver-type transcripts of subunit VIa were 30% and 25% from total VIa transcripts (VIaL+VIaH), respectively, but decrease to only 2-5% at adult state. The liver-type transcripts of subunit VIIa occur to 50% in fetal heart and skeletal muscle, which remained unchanged in adult heart and decrease to 5-8% in adult skeletal muscle. The results clearly indicate a switch of gene expression in heart and skeletal muscle during development, from the liver type to the heart/muscle type of subunit VIa (and partly VIIa).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223633     DOI: 10.1111/j.1432-1033.1993.tb18342.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  19 in total

Review 1.  Evolution of the couple cytochrome c and cytochrome c oxidase in primates.

Authors:  Denis Pierron; Derek E Wildman; Maik Hüttemann; Thierry Letellier; Lawrence I Grossman
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Subunit change in cytochrome c oxidase: identification of the oxygen switch in Dictyostelium.

Authors:  R Bisson; S Vettore; E Aratri; D Sandona
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

3.  Mice deleted for heart-type cytochrome c oxidase subunit 7a1 develop dilated cardiomyopathy.

Authors:  Maik Hüttemann; Scott Klewer; Icksoo Lee; Alena Pecinova; Petr Pecina; Jenney Liu; Michael Lee; Jeffrey W Doan; Douglas Larson; Elise Slack; Bita Maghsoodi; Robert P Erickson; Lawrence I Grossman
Journal:  Mitochondrion       Date:  2011-11-20       Impact factor: 4.160

4.  Protein phosphorylation and prevention of cytochrome oxidase inhibition by ATP: coupled mechanisms of energy metabolism regulation.

Authors:  Rebeca Acin-Perez; Domenico L Gatti; Yidong Bai; Giovanni Manfredi
Journal:  Cell Metab       Date:  2011-06-08       Impact factor: 27.287

5.  The COX8 gene is not the disease gene of the CMH4 locus in familial hypertrophic cardiomyopathy.

Authors:  G Bonne; L Carrier; K Schwartz; M Komajda
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

6.  Both nuclear and mitochondrial cytochrome c oxidase mRNA levels increase dramatically during mouse postnatal development.

Authors:  K Kim; A Lecordier; L H Bowman
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

Review 7.  Human cytochrome c oxidase: structure, function, and deficiency.

Authors:  J W Taanman
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

8.  Changes of mitochondrial cytochrome c oxidase and FoF1 ATP synthase subunits in rat cerebral cortex during aging.

Authors:  V G Nicoletti; E A Tendi; C Lalicata; S Reale; A Costa; R F Villa; N Ragusa; A M Giuffrida Stella
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

Review 9.  Cytochrome c oxidase: evolution of control via nuclear subunit addition.

Authors:  Denis Pierron; Derek E Wildman; Maik Hüttemann; Gopi Chand Markondapatnaikuni; Siddhesh Aras; Lawrence I Grossman
Journal:  Biochim Biophys Acta       Date:  2011-07-23

Review 10.  Regulation of energy transduction and electron transfer in cytochrome c oxidase by adenine nucleotides.

Authors:  B Kadenbach; J Napiwotzki; V Frank; S Arnold; S Exner; M Hüttemann
Journal:  J Bioenerg Biomembr       Date:  1998-02       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.